Abstract
Trans-resveratrol is a nutraceutical with known antioxidant, anti-inflammatory, cardioprotective, and anti-apoptotic properties. The aim of this study was to evaluate the effects of resveratrol on heart mitochondria. Resveratrol significantly decreased Fe2+ + ascorbate oxidant system-induced lipid peroxide levels, preserved physiological levels of glutathione, and increased nitric oxide (NO) levels in mitochondria. Under calcium-mediated stress, there was a 2.7-fold increase in the NO levels, and a mild decoupling in the mitochondrial respiratory chain. These results provide a mechanism for and support the beneficial effects of resveratrol under pathological conditions induced by oxidative stress and calcium overload. In addition, these findings underscore the usefulness of resveratrol in the prevention of cardiovascular diseases.
Similar content being viewed by others
References
Åkerboom TP, Siess H (1981) Meth Enzymol 77:373–382
Ananthakrishnan R, Kaneko M, Hwang YC, Quadri N, Gómez T, Li Q, Caspersen C, Ramasamy R (2009) Am J Physiol Heart Circ Physiol 296:H333–H341
Arunachalam G, Yao H, Sundar IK, Caito S, Rahman I (2010) Biochem Biophys Res Commun 393:66–72
Blake GJ, Ridker PM (2001) Circ Res 89:763–771
Borutaite V, Jekabsone A, Morkuniene R, Brown GC (2003) J Mol Cell Cardiol 35:357–366
Buege JA, Aust SD (1978) Meth Enzymol 52:302–310
Calderón-Cortés E, Cortés-Rojo C, Clemente-Guerrero M, Manzo-Ávalos S, Villalobos-Molina R, Boldogh I, Saavedra-Molina A (2008) Mitochondrion 8:262–272
Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Skene AM (2004) N Engl J Med 350:1495–1504
Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) N Engl J Med 324:1149–1155
Cortés-Rojo C, Calderón-Cortés E, Clemente-Guerrero M, Manzo-Ávalos S, Uribe S, Boldogh I, Saavedra-Molina A (2007) Free Radic Res 41:1212–1223
Cortés-Rojo C, Calderón-Cortés E, Clemente-Guerrero M, Estrada-Villagómez M, Manzo-Ávalos S, Mejía-Zepeda R, Boldogh I, Saavedra-Molina A (2009) J Bioenerg Biomembr 41:15–28
Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS (2009) Free Radic Biol Med 46:1589–1597
Dedkova EN, Ji X, Lipsius SL, Blatter LA (2004) Am J Physiol Cell Physiol 286:C406–C415
Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Pérez-Pinzón MA (2009) Neuroscience 159:993–1002
Fan X, Mattheis JP (2001) J Food Sci 66:200–203
Ghafourifar P, Richter C (1997) FEBS Lett 418:291–296
Ghafourifar P, Saavedra-Molina A (2006) In: Lamas S, Cadenas E (eds) Nitric oxide, cell signaling, and gene expression. CRC Taylor and Francis, New York, pp 77–98
Gornall AG, Bardawill CJ, David MM (1949) J Biol Chem 177:751–766
Green LC, Wagner DA, Glogowski J, Skipper PI, Wishnok JS, Tannenbaum SR (1982) Anal Biochem 126:131–138
Griffiths EJ, Rutter GA (2009) Biochim Biophys Acta 1787:1324–1333
Gunter TE, Gunter KK, Sheu Sh-Sh, Gavin CE (1994) Am J Physiol 267:C313–C339
Hattori R, Otani H, Maulik N, Das DK (2002) Am J Physiol Heart Circ Physiol 282:H1988–H1995
Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK (2002) Br J Pharmacol 135:1627–1633
Jia Z, Zhu H, Misra BR, Mahaney JE, Li Y, Misra HP (2008) Mol Cell Biochem 313:187–194
Karlsson J, Emgard M, Brundin P, Burkitt MJ (2000) J Neurochem 75:141–150
Kim HJ, Chang EJ, Cho SH, Chung SK, Park HD, Choi SW (2002) Biosci Biotechnol Biochem 66:1990–1993
Labinskyy N, Csiszar A, Veress G, Stef G, Pacher P, Oroszi G, Wu J, Ungvari Z (2006) Curr Med Chem 13:989–996
Leary SC, Michaud D, Lyons CN, Hale TM, Bushfield TL, Adams MA, Moyes CD (2002) Am J Physiol Heart Circ Physiol 283:H540–H548
Lu C, Armstrong JS (2007) Biochem Biophys Res Commun 363:572–577
Moreno-Sánchez R, Hansford GR (1988) Biochem J 256:403–412
Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willet WC, Rimm EB (2003) N Engl J Med 348:109–118
Paradies G, Petrosillo G, Di Pistolese M, Venosa N, Federici A, Ruggiero FM (2004) Circ Res 94:53–59
Patton C (1999) WinMAXC. Version 2.0. Stanford University Hopkins-Marine Station Pacific Grove CA USA
Petrosillo G, Ruggiero FM, Venosa ND, Paradies G (2003) FASEB J 17:714–716
Piper HM, Sezer O, Schleyer M, Schwartz P, Hütter JF, Spieckermann PG (1985) Mol Cell Cardiol 17:885–896
Pirola L, Fröjdo S (2008) IUBMB Life 60:323–332
Raval A, Lin H, Dave K, DeFazio A, Della Morte D, Kim E, Pérez-Pinzón M (2008) Curr Med Chem 15:1545–1555
Rifici VA, Stephan EM, Schneider SH, Khachadurian AK (1999) J Am Coll Nutr 18:137–143
Schrauwen P, Walder K, Ravussin E (1999) Obes Res 7:97–105
Terada H (1990) Environ Health Perspect 87:213–218
Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN, Ping P (2005) Am J Physiol 288:H1290–H1295
Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z (2009) Eur J Pharmacol 604:111–116
Zaninovich A (2005) Medicina (B Aires) 65:163–169
Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD (2005) Mol Cancer Ther 4:1465–1474
Zini R, Morin C, Bertelli A, Bertelli AA, Tillement JP (1999) Drugs Exp Clin Res 25:87–97
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gutiérrez-Pérez, A., Cortés-Rojo, C., Noriega-Cisneros, R. et al. Protective effects of resveratrol on calcium-induced oxidative stress in rat heart mitochondria. J Bioenerg Biomembr 43, 101–107 (2011). https://doi.org/10.1007/s10863-011-9349-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-011-9349-4